Rovi Pharmaceuticals Laboratories
Clinical trials sponsored by Rovi Pharmaceuticals Laboratories, explained in plain language.
-
New injectable treatment shows promise for schizophrenia relapse
Disease control CompletedThis study looked at how well Risperidone ISM works for people with schizophrenia who were hospitalized after a relapse. Researchers tracked 275 patients over 56 days to see if their symptoms improved and if they could better manage daily life. The treatment is given as an inject…
Sponsor: Rovi Pharmaceuticals Laboratories • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Schizophrenia treatment could go from daily pills to four shots a year
Disease control CompletedThis early-phase study tested a new long-acting injection of the antipsychotic drug risperidone that would only need to be given once every three months. Fifty-eight adults with stable schizophrenia received a single shot at different doses to measure how the drug moves through t…
Phase: PHASE1 • Sponsor: Rovi Pharmaceuticals Laboratories • Aim: Disease control
Last updated Jun 26, 2026 15:04 UTC